GlassScriptPhysician profile
Toufic R Jildeh
NPI 1255793311
$89,481.65
in general payments reported to CMS, 2019-2025
25 companies · $24K in 2025
The $24K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,611 · 2020: $1,218 · 2021: $12K · 2022: $36K · 2023: $5,178 · 2024: $4,065 · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Travel and Lodging: $12K · Food and Beverage: $5,725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,450.00 |
| Travel and Lodging | $11,626.67 |
| Food and Beverage | $5,724.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $32,196.79 | 2022-2025 | Arthrex, Knee & Hip Implants Meniscal Repair Fiberstitch, Arthroplasty Implants Revers Total Shoulder Modular Glenoid Systems |
| Smith+Nephew, INC. | $30,974.15 | 2021-2025 | Bone Anchors With Arthroscopic Delivery System, Spatial Frame, Acufex Meniscal Root Repair |
| Exactech, INC. | $5,659.13 | 2019-2023 | |
| Stryker Corporation | $4,583.11 | 2021-2025 | Blueprint Patient Specific Instrumentation, Alphavent, Air |
| Medical Device Business Services, INC. | $3,629.10 | 2019-2021 | |
| Pinnacle, INC | $2,464.38 | 2019 | |
| Medwest Associates | $2,279.40 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $1,631.20 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $1,263.67 | 2019-2022 | |
| Biogen, INC. | $800.00 | 2021 | |
| Djo, LLC | $685.74 | 2019-2023 | Aircast, Donjoy, Procare |
| Lightbody Medical Technologies INC | $678.59 | 2024 | |
| Zak Ortho | $660.97 | 2024-2025 | |
| Miach Orthopaedics, INC. | $431.07 | 2024-2025 | |
| Depuy Synthes Sales INC. | $324.32 | 2019-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $239.09 | 2019-2021 | |
| Anika Therapeutics, INC. | $159.58 | 2023 | Tactoset |
| Abbott Laboratories | $143.33 | 2022 | |
| Vericel Corporation | $115.66 | 2021-2025 | Maci |
| Bioventus LLC | $112.07 | 2021-2025 | Exogen Ultrasound Bone Healing System, Supartz Fx Sodium Hyaluronate |
| Medtronic USA, INC. | $111.18 | 2019 | |
| Evolution Surgical, INC | $111.05 | 2022 | |
| My01 INC. | $107.12 | 2023 | My01 Continuous Compartmental Pressure Monitor |
| Convatec INC. | $100.30 | 2019 | |
| Heron Therapeutics, INC. | $20.65 | 2024 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Toufic Jildeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.